Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Magnetic therapy device aims to heal diabetic foot wounds

NCT ID NCT07465640

Symptom relief Sponsor: National Defence University of Malaysia Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 29, 2026 · Updated 2 times

Summary

This pilot study tests a device called CRAD ULCER X-01 that uses pulsating electromagnetic fields (PEMF) to help heal diabetic foot ulcers. 32 people with chronic, non-healing ulcers will be split into groups receiving standard wound care plus either a placebo or 1-3 hours of PEMF daily for up to three months. Researchers will measure wound healing and tissue changes to see if the device is effective.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Pulsating electromagnetic field (PEMF) therapy via the CRAD ULCER X-01 device
What this could lead to
If it works, this could provide a new, non-invasive way to help heal diabetic foot ulcers faster, reducing the risk of severe complications.
What could go wrong
This is a very small pilot study (32 people) and not yet recruiting. The results may not apply to all patients, and the device's effectiveness is still unproven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 32 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Provision of written consent by subjects. * Subject of either sex. * At least 18 years of age. * Known diabetes mellitus. * Diagnosed with chronic DFU Grade I-III and Stage A according to the University of Texas Classification as recommended in the Malaysian Clinical Practice Guidelines for the Management of Diabetic Foot (2nd Edition). Exclusion Criteria: * Inability or unwillingness to provide written consent. * Inability or unwillingness to comply with the requirements of the protocol as determined by the investigator. * Other medical conditions which, in the investigator's judgement, may be associated with increased risk to the subject or may interfere with study assessments or outcomes. * Participation in another clinical trial and/or recipient of investigational therapy within 4 weeks prior to screening visit. * Patients who have metal implants in any part of the body. * Patients with a pacemaker. * History of malignancies. * Presence of chronic kidney disease co-morbidity. * Presence of severe peripheral artery disease, assessed when the ankle-brachial index (ABI) is \<0.40.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetes mellitus (DM) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

diabetes mellitus Diabetic Foot Inflammation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabetes mellitus (DM) Diabetic foot ulcer

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Tuanku Mizan Armed Forces Hospital

    RECRUITING

    Kuala Lumpur, 57000, Malaysia

More trials for these conditions

Other studies related to the condition(s) this trial covers.